Has Britney Pridgen received payments from drug or device companies?

Yes. Drug and device makers reported $57,080 in general payments to Britney Pridgen across 243 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Britney Pridgen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Britney Pridgen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Britney Pridgen

Psychiatric/Mental Health · Houston, TXNPI 1245839570

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $35,187 of the $57,080 with a category attached, or 61.6%. 12 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 48.0% of the total. Reporting peaked in 2022 at $21,433 and has fallen 67.8% since, to $6,911 in 2025. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,080in general payments, 2019–2025

Across 243 payments — averaging $234.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$27K
Alkermes, Inc.$23K
E.r. Squibb & Sons, L.L.C.$6K
Otsuka Pharmaceutical Development & Commercialization, Inc.$305
Teva Pharmaceuticals USA, Inc.$232
Johnson & Johnson$184
plus $289 from 6 others

What the payments were for

Consulting fees$13,49624%
Speaking & faculty fees$35,18762%
Travel & lodging$3,1456%
Food & beverage$5,2289%
Education$240%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	114	$27,385
Alkermes, Inc.	84	$22,766
E.r. Squibb & Sons, L.L.C.	17	$5,920
Otsuka Pharmaceutical Development & Commercialization, Inc.	11	$305
Teva Pharmaceuticals USA, Inc.	2	$232
Johnson & Johnson	6	$184
Tris Pharma Inc	1	$124
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$82
Corium, LLC	1	$31
Luye Pharma (USA) Ltd.	1	$20
Axsome Therapeutics, Inc.	1	$19
Indivior Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,080 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Other psychiatric/mental health in Houston

Natalie TellezHouston$602K
Linzi LeightonHouston$16K
Samantha SharpeHouston$14K
Jennifer RobinsonHouston$12K
Tracy HicksLongview$684K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →